Tag: Biomanufacturing
Why Defense Tech is Devouring SynBio: Inside the $49 Billion Pivot
By 2026, Synthetic Biology has pivoted to Defense Tech. Explore the $49B shift toward biological sovereignty, material autonomy, and the…
11 Min Read
The Structural Insolvency of Synthetic Platforms
Why Ginkgo’s $930 Million Revenue Gap Forced a Pivot to Vertical Product R&D
8 Min Read
Stop Renting Biology: The Mandatory Pivot to Proprietary Asset Ownership
Synthetic Biology Business Models: Transitioning From Platform Foundries to Asset Creation
8 Min Read

